Ortivus AB ser. B (ORTI-B) - Total Liabilities
Based on the latest financial reports, Ortivus AB ser. B (ORTI-B) has total liabilities worth Skr48.52 Million SEK (≈ $5.22 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Ortivus AB ser. B (ORTI-B) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Ortivus AB ser. B - Total Liabilities Trend (2003–2025)
This chart illustrates how Ortivus AB ser. B's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Ortivus AB ser. B.
Ortivus AB ser. B Competitors by Total Liabilities
The table below lists competitors of Ortivus AB ser. B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CHARWOOD ENERGY EO -01
F:L5Q
|
Germany | €13.81 Million |
|
Serina Therapeutics Inc
NYSE MKT:SER
|
USA | $10.82 Million |
|
Matichon Public Company Limited
BK:MATI
|
Thailand | ฿326.22 Million |
|
UMS-Neiken Group Bhd
KLSE:7227
|
Malaysia | RM6.75 Million |
|
Par Drugs And Chemicals Limited
NSE:PAR
|
India | Rs172.28 Million |
|
YBS International Bhd
KLSE:0025
|
Malaysia | RM117.12 Million |
|
Aurania Resources Ltd
V:ARU
|
Canada | CA$16.68 Million |
|
CXApp Inc.
NASDAQ:CXAI
|
USA | $17.05 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Ortivus AB ser. B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Ortivus AB ser. B (ORTI-B) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.29 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ortivus AB ser. B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ortivus AB ser. B (2003–2025)
The table below shows the annual total liabilities of Ortivus AB ser. B from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr48.52 Million ≈ $5.22 Million |
-31.74% |
| 2024-12-31 | Skr71.07 Million ≈ $7.65 Million |
+28.29% |
| 2023-12-31 | Skr55.40 Million ≈ $5.96 Million |
+2.00% |
| 2022-12-31 | Skr54.31 Million ≈ $5.85 Million |
+26.27% |
| 2021-12-31 | Skr43.02 Million ≈ $4.63 Million |
-8.23% |
| 2020-12-31 | Skr46.87 Million ≈ $5.04 Million |
+79.00% |
| 2019-12-31 | Skr26.19 Million ≈ $2.82 Million |
+2.63% |
| 2018-12-31 | Skr25.52 Million ≈ $2.75 Million |
+34.40% |
| 2017-12-31 | Skr18.98 Million ≈ $2.04 Million |
-54.82% |
| 2016-12-31 | Skr42.02 Million ≈ $4.52 Million |
-21.72% |
| 2015-12-31 | Skr53.68 Million ≈ $5.78 Million |
-15.40% |
| 2014-12-31 | Skr63.46 Million ≈ $6.83 Million |
+224.27% |
| 2013-12-31 | Skr19.57 Million ≈ $2.11 Million |
-11.07% |
| 2012-12-31 | Skr22.00 Million ≈ $2.37 Million |
+0.01% |
| 2011-12-31 | Skr22.00 Million ≈ $2.37 Million |
+32.86% |
| 2010-12-31 | Skr16.56 Million ≈ $1.78 Million |
-79.17% |
| 2009-12-31 | Skr79.50 Million ≈ $8.56 Million |
+6.34% |
| 2008-12-31 | Skr74.76 Million ≈ $8.05 Million |
-17.32% |
| 2007-12-31 | Skr90.42 Million ≈ $9.73 Million |
-16.17% |
| 2006-12-31 | Skr107.87 Million ≈ $11.61 Million |
-14.76% |
| 2005-12-31 | Skr126.55 Million ≈ $13.62 Million |
+267.92% |
| 2004-12-31 | Skr34.40 Million ≈ $3.70 Million |
-7.77% |
| 2003-12-31 | Skr37.29 Million ≈ $4.01 Million |
-- |
About Ortivus AB ser. B
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more